UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Samsung Biologics makes CDO partnership with Taiwanese bio-venture
by Lee Han-soo
2020-03-17 17:31
Celltrion Healthcare launches anticancer biosimilar Herzuma in US
by Lee Han-soo
2020-03-17 16:21
‘Celltrion to invest ₩20 billion to develop COVID-19 cure in 6 months’
by Lee Han-soo
2020-03-13 17:38
SK Bioscience threatens MSD's sway over shingles vaccine market
by Lee Han-soo
2020-03-12 17:05
Bridge Biotherapeutics, Atomwise to develop new drugs using AI
by Lee Han-soo
2020-03-10 12:26
라인
Celltrion applies for approval of new Humira biosimilar to EMA
by Shim Hyun-tai
2020-03-09 16:40
Celltrion Healthcare’s 2019 sales top ₩1 trillion
by Lee Han-soo
2020-03-06 17:31
Samsung BioLogics, STCube to develop immunotherapies
by Lee Han-soo
2020-03-03 16:18
Celltrion Healthcare presents Remsima SC in UK
by Lee Han-soo
2020-03-02 17:42
HLB seeks new pipelines by taking over US biotech firm
by Jeong Sae-im
2020-02-21 15:42
라인
Celltrion’s annual revenue surpassed ₩1 trillion in 2019
by Jeong Sae-im
2020-02-20 15:47
Prescription of Celltrion’s Remsima SC started in Germany
by Jeong Sae-im
2020-02-18 16:05
Korea University analyzes 5,000 cancer patients’ genomic data
by Kim Yun-mi
2020-02-11 15:49
Sillajen's loss more than doubles due to Pexa-Vec trial failure
by Jeong Sae-im
2020-02-03 16:08
Kolon CEO arrested for mislabeling Invossa’s ingredient
by Jeong Sae-im
2020-02-03 15:34
라인
Interpark embarks on organoid business
by Park Gi-taek
2020-01-27 11:18
Samsung BioLogics’ annual sales up 30% on contract research growth
by Jeong Sae-im
2020-01-23 14:47
Celltrion Group to build biopharmaceutical plant in China
by Lee Han-soo
2020-01-21 18:00
Korea’s biopharma power shines at JP Morgan Healthcare meet
by Jeong Sae-im
2020-01-17 15:20
HLB stocks fall in after-hours trading due to interview on rivoceranib
by Jeong Sae-im
2020-01-16 15:46
-
1
2
3
4
5
6
7
8
9
10
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top